Anticancer Effect of Cardamom Extract on Hep-2 Cell Line
Mariam Zaki, Heba Farag, Sara Abd El Wahed
International Dental Journal · 2021
doi:10.1016/j.identj.2021.08.031 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Aim or Purpose: To investigate the anticancer effect of Cardamom extract on Hep-2 cell line which may aid in development of a novel treatment modality to Head and Neck Squamous Cell Carcinoma. Materials and Methods: Hep-2 cell line was divided into five groups: one control group, two groups treated with Cardamom extract, and another two treated with Doxorubicin, each of the two treatments was applied for 24 and 48 hours, respectively. Then, cellular viability was measured using microculture tetrazolium assay, cell cycle analysis was done using Flow Cytometry and eventually, apoptotic activity was evaluated using enzyme-linked immunosorbent assay to measure the concentration of BAX protein and real time polymerase chain reaction to measure the fold change for caspase-3 enzyme. Results: Cardamom extract succeeded to decrease the percentage of viable and proliferating cells with increasing dose. On the other hand, it increased the percentage of apoptotic cells and levels of caspase-3 and BAX protein. Conclusions: Cardamom extract has a potential cytotoxic effect on Head and Neck Squamous Cell Carcinoma cell line in a dose and time dependent manner, and exerts this action through induction of apoptosis, and its action is comparable to Doxorubicin action.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.